Tranylcypromine Sulfate Tablet, Film Coated
NDC Package 0591-5590-01
Package Information
Tranylcypromine Sulfate tablets is tranylcypromine is an antidepressant (monoamine oxidase inhibitor). This formulation utilizes a tablet, film coated delivery system. Marketed by Actavis Pharma, Inc., this product is identified by NDC 0591-5590 and is authorized under FDA application NDA012342.
Identification & Billing
- RxCUI: 313447 - tranylcypromine sulfate 10 MG Oral Tablet
- RxCUI: 313447 - tranylcypromine 10 MG Oral Tablet
- RxCUI: 313447 - tranylcypromine (as tranylcypromine sulfate) 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0591 - Actavis Pharma, Inc.
- 0591-5590 - Tranylcypromine Sulfate
- 0591-5590-01 - 100 TABLET, FILM COATED in 1 BOTTLE
- 0591-5590 - Tranylcypromine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0591-5590-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Tranylcypromine Sulfate, a human prescription drug labeled by Actavis Pharma, Inc.. This tablet, film coated is formulated for oral use and contains tranylcypromine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actavis Pharma, Inc. on February 05, 2016. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Tranylcypromine is an antidepressant (monoamine oxidase inhibitor). This medication treats depression by restoring the balance of certain natural substances (neurotransmitters) in the brain. Tranylcypromine can improve your mood and feelings of well-being. Usually, this medication is used in persons who have not responded to treatment with other drugs.
How is this Actavis Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00591559001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.